PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
agilon health, inc. (AGL)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US00857U1079

CUSIP

00857U107

Sector

Healthcare

IPO Date

Apr 15, 2021

Highlights

Market Cap

$1.27B

EPS (TTM)

-$0.76

Total Revenue (TTM)

$4.54B

Gross Profit (TTM)

$31.35M

EBITDA (TTM)

-$133.99M

Year Range

$1.50 - $7.73

Target Price

$2.99

Short %

26.64%

Short Ratio

8.72

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
AGL vs. COST AGL vs. QQQ
Popular comparisons:
AGL vs. COST AGL vs. QQQ

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in agilon health, inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%AugustSeptemberOctoberNovemberDecember2025
-90.03%
43.79%
AGL (agilon health, inc.)
Benchmark (^GSPC)

Returns By Period

agilon health, inc. had a return of 62.63% year-to-date (YTD) and -51.49% in the last 12 months.


AGL

YTD

62.63%

1M

64.36%

6M

-55.15%

1Y

-51.49%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

1.96%

1M

2.21%

6M

8.93%

1Y

23.90%

5Y*

12.52%

10Y*

11.46%

*Annualized

Monthly Returns

The table below presents the monthly returns of AGL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-53.07%4.07%-0.49%-9.84%14.55%3.81%5.35%-40.78%-3.68%-35.11%-18.04%-9.09%-84.86%
202334.82%-2.53%11.98%2.19%-18.09%-12.78%10.44%-7.47%0.23%1.35%-41.00%18.17%-22.24%
2022-38.59%21.95%25.37%-29.90%7.48%14.29%14.66%-16.98%12.70%-15.24%-11.54%-8.09%-40.22%
20211.71%13.99%12.88%-9.32%-4.87%-25.11%-6.52%-10.20%22.73%-12.90%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AGL is 15, meaning it’s performing worse than 85% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AGL is 1515
Overall Rank
The Sharpe Ratio Rank of AGL is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of AGL is 1717
Sortino Ratio Rank
The Omega Ratio Rank of AGL is 1919
Omega Ratio Rank
The Calmar Ratio Rank of AGL is 1212
Calmar Ratio Rank
The Martin Ratio Rank of AGL is 1111
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for agilon health, inc. (AGL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for AGL, currently valued at -0.61, compared to the broader market-2.000.002.004.00-0.612.06
The chart of Sortino ratio for AGL, currently valued at -0.60, compared to the broader market-4.00-2.000.002.004.00-0.602.74
The chart of Omega ratio for AGL, currently valued at 0.93, compared to the broader market0.501.001.502.000.931.38
The chart of Calmar ratio for AGL, currently valued at -0.60, compared to the broader market0.002.004.006.00-0.603.13
The chart of Martin ratio for AGL, currently valued at -1.31, compared to the broader market-10.000.0010.0020.00-1.3112.84
AGL
^GSPC

The current agilon health, inc. Sharpe ratio is -0.61. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of agilon health, inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
-0.61
2.06
AGL (agilon health, inc.)
Benchmark (^GSPC)

Dividends

Dividend History


agilon health, inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-92.86%
-1.54%
AGL (agilon health, inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the agilon health, inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the agilon health, inc. was 96.37%, occurring on Nov 18, 2024. The portfolio has not yet recovered.

The current agilon health, inc. drawdown is 92.86%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.37%Jun 21, 2021860Nov 18, 2024
-12.99%May 10, 20214May 13, 20216May 21, 202110
-9.56%Jun 2, 20214Jun 7, 20216Jun 15, 202110
-5.62%Apr 21, 20212Apr 22, 20219May 5, 202111
-3.23%Apr 16, 20211Apr 16, 20211Apr 19, 20212

Volatility

Volatility Chart

The current agilon health, inc. volatility is 26.77%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%AugustSeptemberOctoberNovemberDecember2025
26.77%
5.07%
AGL (agilon health, inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of agilon health, inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for agilon health, inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab